AAAAAA

   
Results: 1-22 |
Results: 22

Authors: Neurath, MF
Citation: Mf. Neurath, Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question (vol 22, pg 21, 2001), TRENDS IMMU, 22(4), 2001, pp. 225-225

Authors: Neurath, MF Finotto, S Fuss, I Boirivant, M Galle, PR Strober, W
Citation: Mf. Neurath et al., Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question, TRENDS IMMU, 22(1), 2001, pp. 21-26

Authors: Linderson, Y French, NS Neurath, MF Pettersson, S
Citation: Y. Linderson et al., Context-dependent Pax-5 repression of a PU.1/NF-kappa B regulated reportergene in B lineage cells, GENE, 262(1-2), 2001, pp. 107-114

Authors: Schlaak, JF Barreiros, AP Pettersson, S Schirmacher, P Zum Buschenfelde, KHM Neurath, MF
Citation: Jf. Schlaak et al., Antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappaB abrogate fulminant septic shock induced by S-typhimurium in mice, SC J IMMUN, 54(4), 2001, pp. 396-403

Authors: Finotto, S Buerke, M Lingnau, K Schmitt, E Galle, PR Neurath, MF
Citation: S. Finotto et al., Local administration of antisense phosphorothioate oligonucleotides to thec-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma, J ALLERG CL, 107(2), 2001, pp. 279-286

Authors: Becker, C Wirtz, S Ma, XJ Blessing, M Galle, PR Neurath, MF
Citation: C. Becker et al., Regulation of IL-12 p40 promoter activity in primary human monocytes: Roles of NF-kappa B, CCAAT/enhancer-binding protein beta, and PU.1 and identification of a novel repressor element (GA-12) that responds to IL-4 and prostaglandin E-2, J IMMUNOL, 167(5), 2001, pp. 2608-2618

Authors: Finotto, S De Sanctis, GT Lehr, HA Herz, U Buerke, M Schipp, M Bartsch, B Atreya, R Schmitt, E Galle, PR Renz, H Neurath, MF
Citation: S. Finotto et al., Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression, J EXP MED, 193(11), 2001, pp. 1247-1260

Authors: Neurath, MF
Citation: Mf. Neurath, Signals on the immune tract, GUT, 49(2), 2001, pp. 164-164

Authors: Jostock, T Mullberg, J Ozbek, S Atreya, R Blinn, G Voltz, N Fischer, M Neurath, MF Rose-John, S
Citation: T. Jostock et al., Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses, EUR J BIOCH, 268(1), 2001, pp. 160-167

Authors: Schurmann, G Ochman, S Neurath, MF
Citation: G. Schurmann et al., Carcinoma of the colon associated with ulcerative colitis, DEUT MED WO, 125(36), 2000, pp. 1045-1050

Authors: Atreya, R Mudter, J Finotto, S Mullberg, J Jostock, T Wirtz, S Schutz, M Bartsch, B Holtmann, M Becker, C Strand, D Czaja, J Schlaak, JF Lehr, HA Autschbach, F Schurmann, G Nishimoto, N Yoshizaki, K Ito, H Kishimoto, T Galle, PR Rose-John, S Neurath, MF
Citation: R. Atreya et al., Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo, NAT MED, 6(5), 2000, pp. 583-588

Authors: Wirtz, S Neurath, MF
Citation: S. Wirtz et Mf. Neurath, Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease, INT J COL R, 15(3), 2000, pp. 144-160

Authors: Rampton, DS Neurath, MF Almer, S D'Haens, G Petritsch, W Stange, EF
Citation: Ds. Rampton et al., Mycophenolate mofetil in Crohn's disease, LANCET, 356(9224), 2000, pp. 163-164

Authors: Neurath, MF Schurmann, G
Citation: Mf. Neurath et G. Schurmann, Immunopathogenesis of inflammatory bowel diseases, CHIRURG, 71(1), 2000, pp. 30-40

Authors: Orth, T Peters, M Schlaak, JF Krummenauer, F Wanitschke, R Mayet, WJ Galle, PR Neurath, MF
Citation: T. Orth et al., Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: A 12-month pilot study, AM J GASTRO, 95(5), 2000, pp. 1201-1207

Authors: Hofmann, MA Drury, S Fu, CF Qu, W Taguchi, A Lu, Y Avila, C Kambham, N Bierhaus, A Nawroth, P Neurath, MF Slattery, T Beach, D McClary, J Nagashima, M Morser, J Stern, D Schmidt, AM
Citation: Ma. Hofmann et al., RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides, CELL, 97(7), 1999, pp. 889-901

Authors: Wirtz, S Finotto, S Kanzler, S Lohse, AW Blessing, M Lehr, HA Galle, PR Neurath, MF
Citation: S. Wirtz et al., Cutting edge: Chronic intestinal inflammation in STAT-4 transgenic mice: Characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4(+) T cells that respond to bacterial antigens, J IMMUNOL, 162(4), 1999, pp. 1884-1888

Authors: Wirtz, S Galle, PR Neurath, MF
Citation: S. Wirtz et al., Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure, GUT, 44(6), 1999, pp. 800-807

Authors: Neurath, MF Wanitschke, R Peters, M Krummenauer, F zum Buschenfelde, KHM Schlaak, JF
Citation: Mf. Neurath et al., Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease, GUT, 44(5), 1999, pp. 625-628

Authors: Fuss, IJ Marth, T Neurath, MF Pearlstein, GR Jain, A Strober, W
Citation: Ij. Fuss et al., Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice, GASTROENTY, 117(5), 1999, pp. 1078-1088

Authors: Hildner, K Finotto, S Becker, C Schlaak, J Schirmacher, P Galle, PR Marker-Hermann, E Neurath, MF
Citation: K. Hildner et al., Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis, CLIN EXP IM, 118(1), 1999, pp. 137-146

Authors: Neurath, MF Hildner, K Becker, C Schlaak, JF Barbulescu, K Germann, T Schmitt, E Schirmacher, P Haralambous, S Pasparakis, M Zum Buschenfelde, KHM Kollias, G Marker-Hermann, E
Citation: Mf. Neurath et al., Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression, CLIN EXP IM, 115(1), 1999, pp. 42-55
Risultati: 1-22 |